<?xml version="1.0" encoding="UTF-8"?>
<p>Human and veterinary medicinal products can be authorised in the EU either via a centralised EU system (by the European Medicines Agencyâ€”EMA) or by EU national medicines agencies. There is currently no harmonised framework in the EU for the medical or recreational use of cannabis. Some form of medical cannabis is now legal in more than 22 EU countries. Several human cannabis-derived medicinal products have been authorised either via EMA or via EU national medicines agencies (see 
 <xref rid="animals-11-00892-t001" ref-type="table">Table 1</xref>). As of February 2020, there are 17 active clinical trials that involve investigating the efficacy of cannabis and cannabinoid medications against diseases ranging from schizophrenia to endometriosis [
 <xref rid="B44-animals-11-00892" ref-type="bibr">44</xref>].
</p>
